---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-002057"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:42:31.819210+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma director Surendra Ajjarapu resigns effective Jan 7, 2026

## Summary
- Surendra Ajjarapu resigned as Director of Aspire Biopharma, effective January 7, 2026.
- Resignation not due to any disagreement with the Company, Board, or management.
- No replacement for the vacant director position has been announced.

## SEC filing metadata
- accession: 0001493152-26-002057
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/0001493152-26-002057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226002057/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-002057
- JSON: https://secwatch.observer/filing/0001493152-26-002057.json
- Plain text: https://secwatch.observer/filing/0001493152-26-002057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.